Screener
Xeris Biopharma Holdings, Inc. XERS Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Xeris Biopharma Holdings, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001867096-26-000065
FAQ
- What is Xeris Biopharma Holdings, Inc.'s operating margin?
- Xeris Biopharma Holdings, Inc. (XERS) reported operating margin of 10.9% in Q2 2026.
- How has Xeris Biopharma Holdings, Inc.'s operating margin changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s operating margin increased by 333.4% year-over-year, from -4.7% to 10.9%.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s operating margin?
- Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s operating margin has grown at a -56.2% compound annual growth rate (CAGR), from -232.2% to 8.5%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Xeris Biopharma Holdings, Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude